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Abstract: Effect of two antifilarials ivermectin (microfilaricidal) and CDRI Comp. 82/437
(macrofilaricidal) in combination with immunostimulator (CDRI Comp. 86/448) was evaluated on
establishment of Acanthocheilonema viteae infection in Mastomys coucha. The immunostimulator
along with the antifilarials was administered on single occasion (Day 0 of larval exposure). Im-
munostimulator when given in combination with macrofilaricidal agent (82/437), revealed sig-
nificantly less percentage of wormrecovery over untreated control as well as over treated (with
either immunostimulator or antifilarial alone) infected controls. It is, thus surmised that estab-
lishment of filarial infection is affected by immunostimulant along with antifilarial agent.
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INTRODUCTION
Filariasis is a major parasitic disease of great public health importance affecting millions of
people in India alone (NICD, 1994). Apart from chemotherapeutic measures, control of the disease
in endemic areas largely depends upon the efficient preventive measures such as protection from
infective larval invasion from vector bites. It is now well documented that like many other
parasitic infections, filarial parasites also cause immunosuppression (Portaro et al, 1976; Ottesen
et al, 1977; Piessens et al, 1980, a, b) which help them in their establishment in the host.
Stimulation of host's immuneresponsiveness by use of immunomodulators thus appears to be a
logical approach in counteracting establishment process of infective larvae. This has been amply
substantiated from our earlier studies in which establishment of A. viteae and B. malayi infections
has been shown to be jeopardized significantly when host was primed with immunomodulators
before infective exposure (Misra et al, 1991; Murthy et al, 1992). On the other hand there are
certain antifilarial agents which are knownto act only partially on developing forms of filariae.
Combination therapy with such antifilarial agents along with immunopotentiator appears to be a
practical proposition in crusade against establishment of invading and developing larvae in the
host.
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Previous studies in our laboratory have indicated that chemotherapeutic efficacy of an-
tifilarial agent can also be enhanced by using it along with immunomodulators (Chatterjee et al,
1988; Fatma et al, 1994). Thus, application of combination of immunostimulator and antifilarial
agent might exert better and more efficient protection against infection. In the present study,
efforts have been made to prevent the establishment of Acanthocheilonema viteae in Mastomys
coucha with combination therapy using CDRI compound 82/437 or ivermectin along with a syn-
thetic immunostimulator, CDRI Compound 86/448.
MATERIALS AND METHODS
Experimental model: Acanthocheilonema viteae in Mastomys coucha was used as experimental
model. Six to eight weeks old male mastomys were exposed subcutaneously with 50 infective
larvae (L3) of A. viteae collected from freshly dissected infected ticks (Ornithodoros moubata)
following broadly the technique of Singh et al. (1988).
Immunomodulator: CDRI Compound 86/448, a synthetic glycopeptide, was used in the present
study as immunostimulator. The Compound 86/448 is a structurally related congenor of muramyl
dipeptide (MDP) and was originally synthesized in this Institute (Haq et al, 1990).
Antifilarials: Two antifilarials used in the study were ivermectin and a synthetic agent, com-
pound 82/437. Ivermectin was procured from Merck Sharpe and Dohme, New Jersey. The
compound 82/437 was originally synthesized in this Institute (Abuzar et al, 1986). The agent is a
benzimidazole derivative (2,2' Dicarbomethoxy amino 5-5' dibenzimidazolyl ketone) having
macrofilaricidal activity against three filarial species L. carinii, A. viteae and B. malayi in rodents
(Fatma et al, 1989).
Drugpreparation and Doseschedule: Compound 86/448 was prepared in sterile distilled water
and used at a dose of 250^g/animal on single occasion subcutaneously. Ivermectin and compound
82/437 were used at 15^g/kg x 1 and 100mg/kg x 1 orally respectively. Both the compounds were
prepared in distilled water containing 0.1% Tween-80. Dose of antifilarials and immunomodu-
lator corresponded to the ED50 values.
Experiment: Four experimental groups, each consisting of 8- 10 animals were used. Different
groups receiving treatment and controls were:
1) treated with antifilarials only (ivermectin/Comp. 82/437).
2) treated with immunomodulator only (86/448).
3) treated simultaneously with antifilarial and immunomodulator.
4) untreated controls.
Animals belonging to different experimental groups were exposed to 50 L3 of A viteae 2 hrs
after administration of drug and/or immunomodulator. Untreated animals were also exposed
under identical conditions. The effect of individual or combination of drugs was assessed by ob-
serving recovery of adult parasites on day 60 i. e., at the start of patency of infection.
Adult wormrecovery: On day 60 of infective exposure, adult parasites were recovered from
subcutaneous tissues of the infected animals. The percentage reduction in worm recovery was
calculated by comparing the number of live adult worms recovered from experimental animals
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with that recovered from untreated infected controls.
Statistical analysis: The data was analysed and p values were taken out using Student's T test.
RESULTS
Effect of Compounds 86/448 and ivermectin: Table 1 shows the effect of 86/448, ivermectin and
their combination on establishment of A viteae infection in mastomys. Treatment with compound
86/448 and ivermectin resulted in 60.2% reduction in adult worm recovery over control (p < 0.01).
Ivermectin and compound 86/448 individually exerted respectively 52.8% and 42.9% reduction in
wormrecovery over untreated infected control.
Table 1. Effect of ivermectin, compound 82/437 and their combination with immunomodulator compound
86/448 on establishment of A. viteae infection in M. coucha
N°' of. No. of worms "÷T	5¢/uP”1"÷W,^^M^Uá"%̂reductionin %reductionin
Treatment Dose* frná"f recovered *á"f worm wormrecovery
exts)» Mean±SD of worms recovery overcontrol
I vermectin ( I ) 15//g/kgx 1 10 (3) 13.4±4.6
82/437 (1) lOOmg/kgx l 12 (3) 18.5±5.4
86/448 (1) 250//g/animalx l 12 (3) 16.2±4.4
Ivermectin (F) 15j«g/kgx l 10 (3) ll.3±1.5
887448 250^g/animal x l
82/437 (V) lOOmg/kg x ! 12 (3)
86/t448 25^/g/animal x 1
I nfectedcontrol
4 .3±3.8
















C omp.86/448 was administered subcutaneously whereas other agents were fed orally
*A11 animals were exposed to 50 L3 of A. viteae
Table la. Statistical significance of percent reduction in worm recovery
(over control) amongst treated groups.
























F =Ivermectin + 86/448
V = 82/437 + 86/448
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Effect of compounds 86/448 and 82/437: A significant reduction (84.8%) in establishment of A.
viteae infection was observed when animals were exposed following treatment with combination
of compounds 86/448 and 82/437. Compound 82/437 alone exerted 34.8% reduction in adult worm
recovery over controls (Table 1). Statistical significance of percent reduction in wormrecovery
(over control) amongst treated groups is shown in Table la.
DISCUSSION
Control of fillariasis appears difficult in absence of any effective marcrofilaricide. Never-
theless, continuous infective larval exposure through vectors in endemic area challenges our
strategies in chemotherapy. One of the major logistics for control of filariasis would be the pro-
tection of the population from establishment in host. This can be achieved either by vector control
or by drugs having lethal effect on developing forms of filarial larvae in the host. The latter
strategy i. e. control by use of filarial larvicidal agents has been evaluated in the present inves-
tigation. Earlier, a number of attempts on prophylaxis by chemical agents have been made using
single or combination of antifilarial agents against different experimental filarial infections
(Denham and Brandte, 1980; Zahner et al, 1987; McCall et al, 1993). Most of these studies
however, did not yield desired results. The existing drug diethylcarbamazine (DEC) has strong
effect on microfilariae but its effect on other developing forms of target parasite, W.bancrofti is
not convincing (Jordan, 1958). However, the drug has been shown to be larvicidal with multiple
doses as revealed in several experimental studies (Denham et al, 1978; Mak and Lim, 1983) in-
cluding its use as chemoprophylactic agent against loaisis (Duke 1963).
As immunesystem plays an important role in exertion of drug activity in host (Ottesen et.
al, 1977; Kwaand Mak, 1980; Piessens et al, 1980) the strategy taken up in the present study is
to boost the antifilarial larvicidal activity potential of the drug with the help of an im-
munostimulator. Two candidate antifilarials CDRI compound 82/437 and ivermectin which have
been shown earlier to exert moderate action against infective larvae (Fatma et al, 1989; Singh et
al, 1990) have been used in the present investigation along with immunostimulator to potentiate
their larvicidal property. It may be recalled that certain immunostimulators themselves can effect
to an extent the growth, development and establishment of larvae in the host (Misra et al, 1991;
Murthy et al, 1992).
The single dose therapy with any individual antifilarial agent led to 35 to 53% effect on
establishment of adult wormswhen compared with controls. The maximumefficacy of 53% was
demonstrated with ivermectin alone followed by immunostimulator compound 86/448 with 42.9%
activity and an activity of 34.8% was displayed by the adulticidal agent, compound 82/437. It is
interesting to observe that though no significant enhancement in activity against wormestab-
lishment occurred with combination of ivermectin and the immunostimulator, very significant
improvement in action of 82/437 occurred when this antifilarial was administered along with
immunostimulator. The better performance of combination of 82/437 and immunostimulator
(86/448) was primarily due to complementary action of the two agents against establishment of
filariids. In our earlier studies (Misra et. al, 1991) it was shown that peptide immunostimulators
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like MDP and its derivatives could suppress filarial establishment in rodent hosts and subsequent
development of microfilaraemia through enhancement in activity of reticuloendothelial system
including macrophage functioning. A. viteae used in the present study is known to be susceptible
to reactive oxygen intermediates (Batra et al, 1990). Nevertheless, the parasite also possesses an
active enzyme system like SOD and catalase to protect itself against host's oxidant attack.
Compound 82/437 inhibits host's oxidant attack. Compound 82/437 also inhibits significantly the
antioxidants (catalase and glutathione peroxidase) of parasite rendering them prone to H202
toxicity leading to death (Batra et al, 1992). Thus on one hand presently used peptide im-
munostimulator enhanced the release of reactive oxygen intermediates and on the other hand
compound 82/437 disrupted the antioxidant defence system of the parasites leading to chain of
activity against establishment of filarial larvae in the host.
Though the immunostimulator used as combinant with ivermectin was the same, the
mechanism of exertion of activity of the two agents differ (Turner and Schaeffer, 1989; Mak et al,
1991; Pal et al, 1991). None of these thus benefitted from the activity of the other with the result
that no improvement in activity of the combination was observed. The combination of compound
82/437 and the peptide immunostimulator should be investigated further for their efficacy against
establishment of filarial infection in higher models eg. monkey with human filarial infection.
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